Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-cd9895bd7-dk4vv Total loading time: 0 Render date: 2024-12-27T15:17:07.461Z Has data issue: false hasContentIssue false

Section G - Screening and Prophylaxis

Published online by Cambridge University Press:  22 December 2022

Edited by
Mick van Trotsenburg ,
Rixt A. C. Luikenaar  and
Maria Cristina Meriggiola
Mick van Trotsenburg
Affiliation:
Sigmund Freud PrivatUniversität, Wien
Rixt A. C. Luikenaar
Affiliation:
Rebirth Health Center, Utah
Maria Cristina Meriggiola
Affiliation:
Università di Bologna
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Context, Principles and Practice of TransGynecology
Managing Transgender Patients in ObGyn Practice
 , pp. 250 - 284
Publisher: Cambridge University Press
Print publication year: 2022

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

References

Dreher, PC, Edwards, D, Hager, S, et al. Complications of the neovagina in male-to-female transgender surgery: a systematic review and meta-analysis with discussion of management. Clin Anat 2018;31(2):191–199.Google Scholar
Horbach, SE, Bouman, MB, Smit, JM, et al. Outcome of vaginoplasty in male-to-female transgenders: a systematic review of surgical techniques. J Sex Med 2015;12(6):1499–1512.Google Scholar
Pendergrass, PB, Reeves, CA, Belovicz, MW, Molter, DJ, White, JH. Comparison of vaginal shapes in Afro-American, Caucasian and Hispanic women as seen with vinyl polysiloxane casting. Gynecol Obstet Invest 2000;50(1):54–59. https://doi.org/10.1159/000010281. PMID 10895030. S2CID 37395321Google Scholar
Slater, MW, Vinaja, X, Aly, I, et al. Neovaginal construction with pelvic peritoneum: reviewing an old approach for a new application. Clin Anat 2018;31(2):175–180.CrossRefGoogle ScholarPubMed
Levy, JA, Edwards, DC, Cutruzzula-Dreher, P, et al. Male-to-female gender reassignment surgery: an institutional analysis of outcomes, short-term complications, and risk factors for 240 patients undergoing penile-inversion vaginoplasty. Urology 2019;131:228–233.CrossRefGoogle ScholarPubMed
Chen, ML, Reyblat, P, Poh, MM, Chi, AC. Overview of surgical techniques in gender-affirming genital surgery. Transl Androl Urol 2019;8(3):191–208.Google Scholar
Ferrando, CA. Vaginoplasty complications. Clin Plast Surg 2018;45(3):361–368.CrossRefGoogle ScholarPubMed
Mukai, Y, Watanabe, T, Sugimoto, M, Kimata, Y, Namba, Y. Vaginoplasty with a pudendal-groin flap in male-to-female transsexuals. Acta Med Okayama 2017;71(5):399–405.Google Scholar
Selvaggi, G, Bellringer, J. Gender reassignment surgery: an overview. Nat Rev Urol 2011;8(5):274–282.CrossRefGoogle ScholarPubMed
Lawrence, AA. Patient-reported complications and functional outcomes of male-to-female sex reassignment surgery. Arch Sex Behav 2006;35(6):717–727.CrossRefGoogle ScholarPubMed
Gaither, TW, Awad, MA, Osterberg, EC, et al. Postoperative complications following primary penile inversion vaginoplasty among 330 male-to-female transgender patients. J Urol 2018;199(3):760–765.Google Scholar
Ives, GC, Fein, LA, Finch, L et al. Evaluation of BMI as a risk factor for complications following gender-affirming penile inversion vaginoplasty. Plast Reconstr Surg Glob Open 2019;7(3):e2097.Google Scholar
Amies Oelschlager, AM, Kirby, A, Breech, L. Evaluation and management of vaginoplasty complications. Curr Opin Obstet Gynecol 2017;29(5):316–321.Google Scholar
Leong, A. Sexual dimorphism of the pelvic architecture: a struggling response to destructive and parsimonious forces by natural & mate selection. Mcgill J Med 2006;9(1):61–66.Google Scholar
Raigosa, M, Avvedimento, S, Yoon, TS, et al. Male-to-female genital reassignment surgery: a retrospective review of surgical technique and complications in 60 patients. J Sex Med 2015;12(8):1837–1845.Google Scholar
Li, JS, Crane, CN, Santucci, RA. Vaginoplasty tips and tricks [published online ahead of print, 2020 Aug 25]. Int Braz J Urol 2020;46. https://doi.org/10.1590/S1677-5538.IBJU.2020.0338Google Scholar
Perovic, S, Djinovic, R. Genitoplasty in male-to-female transsexuals. Curr Opin Urol 2009;19(6):571–576.Google Scholar
Haedersdal, M, Matzen, P, Wulf, HC-More. Laserepilering: En systematisk oversigt over evidensbaserede kliniske resultater [Laser epilation: a systematic review of evidence-based clinical results]. Ugeskrift for laeger 2000;162(50):6809–6815.Google Scholar
Pariser, JJ, Kim, N. Transgender vaginoplasty: techniques and outcomes. Transl Androl Urol 2019;8(3):241–247.Google Scholar
Greaves, NS, Iqbal, SA, Hodgkinson, T, et al. Skin substitute-assisted repair shows reduced dermal fibrosis in acute human wounds validated simultaneously by histology and optical coherence tomography. Wound Repair Regen 2015;23(4):483–494.Google Scholar
Snyder, DL, Sullivan, N, Schoelles, KM. Skin Substitutes for Treating Chronic Wounds [Internet]. Rockville, MD: Agency for Healthcare Research and Quality (US); December 18, 2012. AHRQ Technology Assessments. PMID: 25356454 NBK248353Google Scholar
Drinane, JJ, Santucci, R. What urologists need to know about male to female genital confirmation surgery (vaginoplasty): techniques, complications and how to deal with them. Minerva Urol Nefrol 2020;72(2):162–172.CrossRefGoogle Scholar
Sheikh, ES, Sheikh, ES, Fetterolf, DE. Use of dehydrated human amniotic membrane allografts to promote healing in patients with refractory non healing wounds. Int Wound J 2014;11(6):711–717.Google Scholar
Davydov, SN. Colpopoeisis from the peritoneum of the uterorectal space. Akusherstvo i ginekologiia 1969;45(12):55.Google Scholar
Wroblewski, P, Gustafsson, J, Selvaggi, G. Sex reassignment surgery for transsexuals. Curr Opin Endocrinol Diabetes Obes 2013;20(6):570–574.Google Scholar
Grimes, MD, Tesdahl, BA, Schubbe, M, et al. Histopathology of anterior urethral strictures: toward a better understanding of stricture pathophysiology. J Urol 2019;202(4):748–756.CrossRefGoogle Scholar
Boas, SR, Ascha, M, Morrison, SD, et al. Outcomes and predictors of revision labiaplasty and clitoroplasty after gender-affirming genital surgery. Plast Reconstr Surg 2019;144(6):1451–1461.Google Scholar
Li, FY, Xu, YS, Zhou, CD, et al. Long-term outcomes of vaginoplasty with autologous buccal micromucosa. Obstet Gynecol 2014;123(5):951–956.Google Scholar
Gupta, A, Francis, S, Stewart, R, Hobson, D, Meriwether, KV. Repair of colonic neovaginal stenosis using a biological graft in a male-to-female transgender patient. Int Urogynecol J 2019;30(4):661–663.Google Scholar
van der Sluis, W, Bouman, M-B, Buncamper, M, et al. Clinical characteristics and management of neovaginal fistulas after vaginoplasty in transgender women. Obstet Gynecol 2016;127(6):1118–1126. https://doi.org/10.1097/AOG.0000000000001421Google Scholar
Crisp, CC, Vaccaro, CM, Estanol, MV, et al. Intra-vaginal diazepam for high-tone pelvic floor dysfunction: a randomized placebo-controlled trial. Int Urogynecol J 2013;24:1915–1923.Google Scholar
Holland, MA, Joyce, JS, Brennaman, LM, et al. Intravaginal diazepam for the treatment of pelvic floor hypertonic disorder: a double-blind, randomized, placebo-controlled trial. Female Pelvic Med Reconstr Surg 2019;25(1):76–81.Google Scholar

References

Bustos, VP, Bustos, SS, Mascaro, A, et al. Regret after gender-affirmation surgery: a systematic review and meta-analysis of prevalence. Plast Reconstr Surg Glob Open 2021;9(3):e3477.Google Scholar
Weijmar Schultz, W, Basson, R, Binik, Y, et al. Women’s sexual pain and its management. J Sex Med 2005;2(3):301–316.Google Scholar
Poone, S, Geolani, WD, Dugi, D. Neovaginal canal dissection in gender affirming vaginoplasty. J Urol 2021; 205(4);1110–1118.Google Scholar
Kuhn, A, Hiltebrand, R, Birkhäuser, M. Do transsexuals have micturition disorders? Eur J Obstet Gynecol Reprod Biol 2007;131(2):226–230.Google Scholar
Hoebeke, P, Selvaggi, G, Ceulemans, P, et al. Impact of sex reassignment surgery on lower urinary tract function. Eur Urol 2005;47(3):398–402.Google Scholar
Valkenet, K, van de IG, Dronkers, JJ, et al. The effects of preoperative exercise therapy on postoperative outcome: a systematic review. Clin Rehab 2011;25(2):99–111.Google Scholar
Wallis, JA, Taylor, NF. Pre-operative interventions (non-surgical and non-pharmacological) for patients with hip or knee osteoarthritis awaiting joint replacement surgery – a systematic review and meta-analysis. Osteoarthr Cartil 2011;19(12):1381–1395.Google Scholar
Saliyan, A, Ozbas, A. The effect of pelvic floor muscle training on incontinence problems after radical prostatectomy. Am J Mens Health 2018;12(4):1007–1015.Google Scholar
Tienforti, D, Sacco, E, Marangi, F, et al. Efficacy of an assisted low‐intensity programme of perioperative pelvic floor muscle training in improving the recovery of continence after radical prostatectomy: a randomized controlled trial. BJU Int 2012;110(7):1004–1010.Google Scholar
Jarvis, SK, Hallam, TK, Lujic, S, Abbott, JA, Vancaillie, TG. Peri-operative physiotherapy improves outcomes for women undergoing incontinence and or prolapse surgery: results of a randomised controlled trial. Aust N Z J Obstet Gynaecol 2005;45(4):300–302.Google Scholar
Nauman, K, Stolzle, A, Owens, L, Frilot, CF 2nd, Gomelsky, A. Impact of preoperative pelvic floor muscle training (pretraining) on urinary storage and emptying symptoms in women undergoing sling surgery. Int Urogynecol J 2021;33(3):673–679.Google Scholar
Manrique, OJ, Adabi, K, Huang, TCT, et al. Assessment of pelvic floor anatomy for male-to-female vaginoplasty and the role of physical therapy on functional and patient-reported outcomes. Ann Plast Surg 2018;82(6):661–666.CrossRefGoogle Scholar
Jiang, DD, Gallagher, S, Burchill, L, Berli, J, Dugi, D. Implementation of a pelvic floor physical therapy program for transgender women undergoing gender-affirming vaginoplasty. Obstet Gynecol 2019;133(5):1003–1011.CrossRefGoogle ScholarPubMed
Frawley, H, Shelly, B, Morin, M, et al. An International Continence Society (ICS) report on the terminology for pelvic floor muscle assessment. Neurourol Urodynam 2021;40(5):1217–1260.CrossRefGoogle ScholarPubMed
Center for Substance Abuse Treatment (US). Trauma-Informed Care in Behavioral Health Services. Rockville, MD: Substance Abuse and Mental Health Services Administration (US); Published 2014. (Treatment Improvement Protocol (TIP) Series, No. 57.) PMID: 24901203.Google Scholar
James, SE, Herman, JL, Rankin, S, et al. The Report of the 2015 U.S. Transgender Survey. Washington, DC: National Center for Transgender Equality. Published 2016. See: https://transequality.org/sites/default/files/docs/usts/USTS-Full-Report-Dec17.pdf [last accessed May 5, 2022].Google Scholar
Pouwels, S, Hageman, D, Gommans, LN, et al. Preoperative exercise therapy in surgical care: a scoping review. J Clin Anesth 2016;33:476–490.Google Scholar
Dronkers, JJ, Chorus, AM, Meeteren, NL, Hopman‐Rock, M. The association of pre‐operative physical fitness and physical activity with outcome after scheduled major abdominal surgery. Anaesthesia 2013;68:67–73.Google Scholar
Mayo, NE, Feldman, L, Scott, S, et al. Impact of preoperative change in physical function on postoperative recovery: argument supporting prehabilitation for colorectal surgery. Surgery 2011;150(3):505–514.CrossRefGoogle ScholarPubMed
Gillis, C, Li, C, Lee, L, et al. Prehabilitation versus rehabilitation. Anesthesiology 2014;121(5):937–947.Google Scholar
Jiang, DD, Gallagher, S, Burchill, L, Berli, J, Dugi, D. Implementation of a pelvic floor physical therapy program for transgender women undergoing gender-affirming vaginoplasty. Obstet Gynecol 2019;133(5):1003–1011.CrossRefGoogle ScholarPubMed
Raphael, KG, Widom, CS. Post-traumatic stress disorder moderates the relation between documented childhood victimization and pain 30 years later. Pain 2011 ;152(1):163–169.Google Scholar
Mazi, B, Kaddour, O, Al-Badr, A. Depression symptoms in women with pelvic floor dysfunction: a case-control study. Int J Womens Health 2019;11:143–148.Google Scholar
Dy, GW, Nolan, IT, Hotaling, J, Myers, JB. Patient reported outcome measures and quality of life assessment in genital gender confirming surgery. Transl Androl Urol 2019;8(3):228–240.CrossRefGoogle ScholarPubMed
Laycock, J. Clinical evaluation of the pelvic floor. In Schussler, B, Laycock, J, Norton, P, Stanton, SL, Eds. Pelvic Floor Re-education. London: Springer-Verlag, 1994, pp. 42–48.Google Scholar
Chevalier, F, Fernandez-Lao, C, Cuesta-Vargas, AI. Normal reference values of strength in pelvic floor muscle of women: a descriptive and inferential study. BMC Womens Health 2014;14:143.Google Scholar
Boden, I, El-Ansary, D, Zalucki, N, et al. Physiotherapy education and training prior to upper abdominal surgery is memorable and has high treatment fidelity: a nested mixed-methods randomised-controlled study. Physiotherapy 2018;104(2):194–202.Google Scholar
Marti, L, Galata, C, Beutner, U, et al. Percutaneous tibial nerve stimulation (pTNS): success rate and the role of rectal capacity. Int J Colorectal Dis 2017;32(6):789–796.Google Scholar
Pedraza, R, Nieto, J, Ibarra, S, Haas, EM. Pelvic muscle rehabilitation: a standardized protocol for pelvic floor dysfunction. Adv Urol 2014;2014:487436. https://doi.org/10.1155/2014/487436Google Scholar
Sakakibara, R, Tsunoyama, K, Hosoi, H, et al. Influence of body position on defecation in humans. Low Urin Tract Symptoms 2010;2(1):16–21.Google Scholar
Scahrdein, JN, Zhao, LC, Nikolavsky, D. Management of vaginoplasty and phalloplasty complications. Urol Clin North Am 2019;46(4):605–618.CrossRefGoogle Scholar
Faubion, SS, Shuster, LT, Bharucha, AE. Recognition and management of nonrelaxing pelvic floor dysfunction. Mayo Clin Proc 2012;87(2):187–193.Google Scholar
Wehbe, SA, Fariello, JY, Whitmore, K. Minimally invasive therapies for chronic pelvic pain syndrome. Curr Urol Rep 2010;11(4):276–285.CrossRefGoogle ScholarPubMed

References

Bosch, FX, Broker, TR, Forman, D, et al. Comprehensive control of HPV infections and related diseases. Vaccine 2013;31(8):11–31.Google Scholar
Doerfler, D, Bernhaus, A, Kottmel, A, et al. Human papilloma virus infection prior to coitarche. Am J Obstet Gynecol 2009;200(5):487.e1–5.Google Scholar
Giuliano, AR, Lee, JH, Fulp, W, et al. Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study. Lancet 2011;377(9769):932–940.Google Scholar
Loverro, G, Di Naro, E, Caringella, AM, et al. Prevalence of human papillomavirus infection in a clinic sample of transsexuals in Italy. Sex Transm Infect 2016;92(1):67–69.Google Scholar
Reisner, SL, Deutsch, MB, Peitzmeier, SM, et al. Test performance and acceptability of self- versus provider-collected swabs for high-risk HPV DNA testing in female-to-male trans masculine patients. PLoS One 2018;13(3):e0190172.CrossRefGoogle ScholarPubMed
Cranston, RD, Carballo-Diéguez, A, Gundacker, H, et al. Prevalence and determinants of anal human papillomavirus infection in men who have sex with men and transgender women. Int J STD AIDS 2019;30(2):154–162.Google Scholar
van der Sluis, WB, Buncamper, ME, Bouman, MB, et al. Prevalence of neovaginal high-risk human papillomavirus among transgender women in the Netherlands. Sex Transm Dis 2016;43(8):503–505.CrossRefGoogle ScholarPubMed
Koutsky, LA, Ault, KA, Wheeler, CM, et al. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 2002;347(21):1645–1651.Google Scholar
Pils, S, Joura, EA. From the monovalent to the nine-valent HPV vaccine. Clin Microbiol Infect 2015;21(9):827–833.CrossRefGoogle Scholar
Garland, SM, Hernandez-Avila, M, Wheeler, CM, et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med 2007;356(19):1928–1943.Google Scholar
Joura, EA, Leodolter, S, Hernandez-Avila, M, et al. Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials. Lancet 2007;369(9574):1693–1702.Google Scholar
Palefsky, JM, Giuliano, AR, Goldstone, S, et al. HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. N Engl J Med 2011;365(17):1576–1585.Google Scholar
Chaturvedi, AK, Graubard, BI, Broutian, T, et al. Effect of prophylactic human papillomavirus (HPV) vaccination on oral HPV infections among young adults in the United States. J Clin Oncol 2018;36(3):262–267.Google Scholar
Joura, EA, Giuliano, AR, Iversen, OE, et al. A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women. N Engl J Med 2015;372(8):711–723.Google Scholar
Huh, WK, Joura, EA, Giuliano, AR, et al. Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16–26 years: a randomised, double-blind trial. Lancet 2017;390(10108):2143–2159.Google Scholar
Drolet, M, Bénard, É, Pérez, N, Brisson, M, HPV Vaccination Impact Study Group. Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis. Lancet 2019;394(10197):497–509.CrossRefGoogle ScholarPubMed
Castellsagué, X, Muñoz, N, Pitisuttithum, P, et al. End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24–45 years of age. Br J Cancer 2011;105(1):28–37.Google Scholar
Van Damme, P, Meijer, CJ, Kieninger, D, et al. A phase III clinical study to compare the immunogenicity and safety of the 9-valent and quadrivalent HPV vaccines in men. Vaccine 2016;34(35):4205–4212.Google Scholar
Joura, EA, Garland, SM, Paavonen, J, et al. Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data. BMJ 2012;344:e1401.Google Scholar
Jentschke, M, Kampers, J, Becker, J, Sibbertsen, P, Hillemanns, P. Prophylactic HPV vaccination after conization: a systematic review and meta-analysis. Vaccine 2020;38(41):6402–6409.Google Scholar
Ghelardi, A, Marrai, R, Bogani, G, et al. Surgical treatment of vulvar HSIL: adjuvant HPV vaccine reduces recurrent disease. Vaccines (Basel) 2021;9(2):83.CrossRefGoogle ScholarPubMed
Hartwig, S, Baldauf, JJ, Dominiak-Felden, G, et al. Estimation of the epidemiological burden of HPV-related anogenital cancers, precancerous lesions, and genital warts in women and men in Europe: potential additional benefit of a nine-valent second generation HPV vaccine compared to first generation HPV vaccines. Papillomavirus Res 2015;1:90–100.Google Scholar
Garland, SM, Steben, M, Sings, HL, et al. Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine. J Infect Dis 2009;199(6):805–814.Google Scholar
Lacey, CJ, Woodhall, SC, Wikstrom, A, Ross, J. 2012 European guideline for the management of anogenital warts. J Eur Acad Dermatol Venereol 2013;27(3):e263–270.Google Scholar
Matsuki, S, Kusatake, K, Hein, KZ, Anraku, K, Morita, E. Condylomata acuminata in the neovagina after male-to-female reassignment treated with CO2 laser and imiquimod. Int J STD AIDS 2015;26(7):509–511.Google Scholar
Labanca, T, Mañero, I. Vulvar condylomatosis after sex reassignment surgery in a male-to-female transsexual: complete response to imiquimod cream. Gynecol Oncol Rep 2017;20:75–77.Google Scholar
Blomberg, M, Friis, S, Munk, C, Bautz, A, Kjaer, S. Genital warts and risk of cancer: a Danish study of nearly 50 000 patients with genital warts. J Infect Dis 2012;205(10):1544–1553.Google Scholar
US Preventive Services Task Force, Curry, SJ, Krist, AH, et al. Screening for cervical cancer: US preventive services task force recommendation statement. JAMA 2018;320(7):674–686.Google Scholar
Committee Opinion No. 512: Health Care for Transgender Individuals. Obstet Gynecol 2011;118(6):1454–1458.Google Scholar
Rollston, Rebekah. Promoting cervical cancer screening among female-to-male transmasculine patients. The Fenway Institute, 2019. Available at: https://fenwayhealth.org/wp-content/uploads/TFIP-28_TransMenCervicalCancerScreeningBrief_web.pdfGoogle Scholar
McDowell, M, Pardee, DJ, Peitzmeier, S, et al. Cervical cancer screening preferences among trans-masculine individuals: patient-collected human papillomavirus vaginal swabs versus provider-administered pap tests. LGBT Health 2017;4(4):252–259.Google Scholar
Peitzmeier, SM, Khullar, K, Reisner, SL, Potter, J. Pap test use is lower among female-to-male patients than non-transgender women. Am J Prev Med 2014;47(6):808–812.Google Scholar
Peitzmeier, SM, Reisner, SL, Harigopal, P, Potter, J. Female-to-male patients have high prevalence of unsatisfactory Paps compared to non-transgender females: implications for cervical cancer screening. J Gen Intern Med 2014;29(5):778–784.CrossRefGoogle ScholarPubMed
Schenck, TL, Holzbach, T, Zantl, N, et al. Vaginal carcinoma in a female-to-male transsexual. J Sex Med 2010;7(8):2899–2902.Google Scholar
Harder, Y, Erni, D, Banic, A. Squamous cell carcinoma of the penile skin in a neovagina 20 years after male-to-female reassignment. Case Rep Br J Plast Surg 2002;55(5):449–451.Google Scholar
Bollo, J, Balla, A, Rodriguez Luppi, C, et al. HPV-related squamous cell carcinoma in a neovagina after male-to-female gender confirmation surgery. Int J STD AIDS 2018;29(3):306–308.Google Scholar
Fernandes, HM, Manolitsas, TP, Jobling, TW. Carcinoma of the neovagina after male-to-female reassignment. J Low Genit Tract Dis 2014;18(2):E43–45.Google Scholar
Fierz, R, Ghisu, GP, Fink, D. Squamous carcinoma of the neovagina after male-to-female reconstruction surgery: a case report and review of the literature. Case Rep Obstet Gynecol 2019;2019:4820396.Google ScholarPubMed
Wang, G, Ferguson, D, Ionescu, DN, et al. HPV-related neovaginal squamous cell carcinoma presenting as lung metastasis after male-to-female gender confirmation surgery. Case Rep Oncol 2020;13(1):17–22.Google Scholar
Urban, RR, Teng, NN, Kapp, DS. Gynecologic malignancies in female-to-male transgender patients: the need of original gender surveillance. Am J Obstet Gynecol 2011;204(5):e9–e12.Google Scholar
Driák, D, Samudovský, M. Could a man be affected with carcinoma of cervix? The first case of cervical carcinoma in trans-sexual person (FtM): case report. Acta Medica (Hradec Kralove) 2005;48(1):53–55.Google Scholar
van der Sluis, WB, Buncamper, ME, Bouman, MB, et al. Symptomatic HPV-related neovaginal lesions in transgender women: case series and review of literature. Sex Transm Infect 2016;92(7):499–501.Google Scholar

References

Baral, SD, Poteat, T, Strömdahl, S, et al. Worldwide burden of HIV in transgender women: a systematic review and meta-analysis. Lancet Infect Dis 2013 (online). https://doi.org/10.1016/S1473-3099(12)70315-8Google Scholar
Frank, TD, Carter, A, Jahagirdar, D, et al. Global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017. Lancet HIV 2019 (online). https://doi.org/10.1016/S2352-3018(19)30196-1Google Scholar
Becasen, JS, Denard, CL, Mullins, MM, Higa, DH, Sipe, TA. Estimating the prevalence of HIV and sexual behaviors among the US transgender population: a systematic review and meta-analysis, 2006–2017. Am J Public Health 2019 (online). https://doi.org/10.2105/AJPH.2018.304727Google Scholar
UNAIDS. Global HIV and AIDS statistics 2019 Fact sheet. Published 2019.Google Scholar
Bukowski, LA, Chandler, CJ, Creasy, SL, et al. Characterizing the HIV care continuum and identifying barriers and facilitators to HIV diagnosis and viral suppression among black transgender women in the United States. J Acquir Immune Defic Syndr 2018 (online). https://doi.org/10.1097/QAI.0000000000001831Google Scholar
Jobson, G, Tucker, A, de Swardt, G, et al. Gender identity and HIV risk among men who have sex with men in Cape Town, South Africa. AIDS Care - Psychol Socio-Medical Asp AIDS/HIV. Published 2018. https://doi.org/10.1080/09540121.2018.1465175Google Scholar
Para, AJ, Gee, SE, Davis, JA. Sexually transmitted infections in LGBT populations. Lesbian Gay Bisexual Transgend Healthcare 2016 (online). https://doi.org/10.1007/978-3-319-19752-4_14Google Scholar
Borda, LJ, Perper, M, Keri, JE. Treatment of seborrheic dermatitis: a comprehensive review. J Dermatolog Treat 2019 (online). https://doi.org/10.1080/09546634.2018.1473554Google Scholar
Chu, C, Selwyn, PA. Diagnosis and initial management of acute HIV infection. Am Fam Physician 2010;81(10):1239–1244.Google Scholar
Wood, SM, Salas-Humara, C, Dowshen, NL. Human immunodeficiency virus, other sexually transmitted infections, and sexual and reproductive health in lesbian, gay, bisexual, transgender youth. Pediatr Clin North Am 2016 (online). https://doi.org/10.1016/j.pcl.2016.07.006Google Scholar
World Health Organization. WHO guidelines for the treatment of genital herpes simplex virus. Published 2016.Google Scholar
Van Gerwen, OT, Jani, A, Long, DM, et al. Prevalence of sexually transmitted infections and human immunodeficiency virus in transgender persons: a systematic review. Transgend Health 2020 (online). https://doi.org/10.1089/trgh.2019.0053Google Scholar
Elfering, L, van der Sluis, WB, Mermans, JF, Buncamper, ME. Herpes neolabialis: herpes simplex virus type 1 infection of the neolabia in a transgender woman. Int J STD AIDS 2017 (online). https://doi.org/10.1177/0956462416685658CrossRefGoogle Scholar
Singh, V, Gratzer, B, Gorbach, PM, et al. Transgender women have higher human papillomavirus prevalence than men who have sex with men: two U.S. Cities, 2012–2014. Sex Transm Dis 2019 (online). https://doi.org/10.1097/OLQ.0000000000001051Google Scholar
Workowski, KA, Bolan, GA. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Reports 2015 (online). https://doi.org/10.1016/j.annemergmed.2015.07.526Google Scholar
van der Sluis, WB, Bouman, MB, Gijs, L, van Bodegraven, AA. Gonorrhoea of the sigmoid neovagina in a male-to-female transgender. Int J STD AIDS 2015 (online). https://doi.org/10.1177/0956462414544725Google Scholar
Yunihastuti, E, Teeratakulpisarn, N, Jeo, WS, et al. Incidence, clearance, persistence and factors related with high-risk anal HPV persistence in South-East Asian MSM and transgender women. AIDS 2020 (online). https://doi.org/10.1097/QAD.0000000000002654Google Scholar
Sullivan, PS, Phaswana-Mafuya, N, Baral, SD, et al. HIV prevalence and incidence in a cohort of South African men and transgender women who have sex with men: the Sibanye Methods for Prevention Packages Programme (MP3) project. J Int AIDS Soc 2020 (online). https://doi.org/10.1002/jia2.25591Google Scholar
Pathela, P, Blank, S, Schillinger, JA. Lymphogranuloma venereum: old pathogen, new story. Curr Infect Dis Rep 2007 (online). https://doi.org/10.1007/s11908-007-0010-7Google Scholar
Radix, AE, Harris, AB, Belkind, U, Ting, J, Goldstein, ZG. Chlamydia trachomatis infection of the neovagina in transgender women. Open Forum Infect Dis 2019 (online). https://doi.org/10.1093/ofid/ofz470CrossRefGoogle Scholar
World Health Organization. WHO 2016 Treatment of Syphilis Guidelines. Published 2016.Google Scholar
Stephens, SC, Bernstein, KT, Philip, SS. Male to female and female to male transgender persons have different sexual risk behaviors yet similar rates of STDs and HIV. AIDS Behav 2011 (online). https://doi.org/10.1007/s10461-010-9773-1Google Scholar
Fernandes, FRP, Zanini, PB, Rezende, GR, et al. Syphilis infection, sexual practices and bisexual behaviour among men who have sex with men and transgender women: a cross-sectional study. Sex Transm Infect 2015 (online). https://doi.org/10.1136/sextrans-2014-051589Google Scholar
Soper, DE, Bump, RC, Hurt, WG. Bacterial vaginosis and trichomoniasis vaginitis are risk factors for cuff cellulitis after abdominal hysterectomy. Am J Obstet Gynecol 1990;163(3):1013–1016. https://doi.org/10.1016/0002-9378(90)91115-sGoogle Scholar
Sevelius, J. “There’s no pamphlet for the kind of sex I have”: HIV-related risk factors and protective behaviors among transgender men who have sex with nontransgender men. J Assoc Nurses AIDS Care 2009 (online). https://doi.org/10.1016/j.jana.2009.06.001Google Scholar
Herbst, JH, Jacobs, ED, Finlayson, TJ, et al. Estimating HIV prevalence and risk behaviors of transgender persons in the United States: a systematic review. AIDS Behav 2008 (online). https://doi.org/10.1007/s10461-007-9299-3Google Scholar
Clements-Nolle, K, Marx, R, Guzman, R, Katz, M. HIV prevalence, risk behaviors, health care use, and mental health status of transgender persons: implications for public health intervention. Am J Public Health 2001 (online). https://doi.org/10.2105/AJPH.91.6.915Google Scholar
Callander, D, Cook, T, Read, P, et al. Sexually transmissible infections among transgender men and women attending Australian sexual health clinics. Med J Aust 2019 (online). https://doi.org/10.5694/mja2.50322Google Scholar
Drückler, S, Daans, C, Hoornenborg, E, et al. HIV and STI positivity rates among transgender people attending two large STI clinics in the Netherlands. Sex Transm Infect 2021 (online). https://doi.org/10.1136/sextrans-2020-054875Google Scholar
Castillo, R, Konda, KA, Leon, SR, et al. HIV and sexually transmitted infection incidence and associated risk factors among high-risk MSM and male-to-female transgender women in Lima, Peru. J Acquir Immune Defic Syndr 2015 (online). https://doi.org/10.1097/QAI.0000000000000667Google Scholar
Shover, CL, DeVost, MA, Beymer, MR, et al. Using sexual orientation and gender identity to monitor disparities in HIV, sexually transmitted infections, and viral hepatitis. Am J Public Health 2018 (online). https://doi.org/10.2105/AJPH.2018.304751Google Scholar
Sahastrabuddhe, S, Gupta, A, Stuart, E, et al. Sexually transmitted infections and risk behaviors among transgender persons (Hijras) of Pune, India. J Acquir Immune Defic Syndr 2012 (online). https://doi.org/10.1097/QAI.0b013e318236bd6fGoogle Scholar
Kojima, N, Park, H, Konda, KA, et al. The PICASSO Cohort: baseline characteristics of a cohort of men who have sex with men and male-to-female transgender women at high risk for syphilis infection in Lima, Peru. BMC Infect Dis 2017 (online). https://doi.org/10.1186/s12879-017-2332-xGoogle Scholar
Galea, JT, Kinsler, JJ, Galan, DB, et al. Factors associated with visible anogenital warts among HIV-uninfected Peruvian men who have sex with men and transwomen: a cross-sectional study. Sex Transm Dis 2015 (online). https://doi.org/10.1097/OLQ.0000000000000253Google Scholar
Buchbinder, SP, Glidden, DV, Liu, AY, et al. HIV pre-exposure prophylaxis in men who have sex with men and transgender women: a secondary analysis of a phase 3 randomised controlled efficacy trial. Lancet Infect Dis 2014 (online). https://doi.org/10.1016/S1473-3099(14)70025-8Google Scholar
Reisner, SL, Vetters, R, White, JM, et al. Laboratory-confirmed HIV and sexually transmitted infection seropositivity and risk behavior among sexually active transgender patients at an adolescent and young adult urban community health center. AIDS Care - Psychol Socio-Medical Asp AIDS/HIV 2015 (online). https://doi.org/10.1080/09540121.2015.1020750Google Scholar
Reisner, SL, White Hughto, JM, Pardee, D, Sevelius, J. Syndemics and gender affirmation: HIV sexual risk in female-to-male trans masculine adults reporting sexual contact with cisgender males. Int J STD AIDS 2016 (online). https://doi.org/10.1177/0956462415602418Google Scholar
Nuttbrock, L, Hwahng, S, Bockting, W, et al. Lifetime risk factors for HIV/sexually transmitted infections among male-to-female transgender persons. J Acquir Immune Defic Syndr 2009 (online). https://doi.org/10.1097/QAI.0b013e3181ab6ed8Google Scholar
Operario, D, Nemoto, T. HIV in transgender communities: syndemic dynamics and a need for multicomponent interventions. J Acquir Immune Defic Syndr 2010 (online). https://doi.org/10.1097/QAI.0b013e3181fbc9ecGoogle Scholar
Gandhi, M, Spinelli, MA, Mayer, KH. Addressing the sexually transmitted infection and HIV syndemic. JAMA 2019 (online). https://doi.org/10.1001/jama.2019.2945Google Scholar
Brennan, J, Kuhns, LM, Johnson, AK, et al. Syndemic theory and HIV-related risk among young transgender women: the role of multiple, co-occurring health problems and social marginalization. Am J Public Health 2012 (online). https://doi.org/10.2105/AJPH.2011.300433Google Scholar
Neumann, MS, Finlayson, TJ, Pitts, NL, Keatley, JA. Comprehensive HIV prevention for transgender persons. Am J Public Health 2017 (online). https://doi.org/10.2105/AJPH.2016.303509Google Scholar
Meyer, IH. Prejudice, social stress, and mental health in lesbian, gay, and bisexual populations: conceptual issues and research evidence. Psychol Bull 2003 (online). https://doi.org/10.1037/0033-2909.129.5.674Google Scholar
Hendricks, ML, Testa, RJ. A conceptual framework for clinical work with transgender and gender nonconforming clients: an adaptation of the minority stress model. Prof Psychol Res Pract 2012 (online). https://doi.org/10.1037/a0029597Google Scholar
Risser, JMH, Shelton, A, McCurdy, S, et al. Sex, drugs, violence, and HIV status among male-to-female transgender persons in Houston, Texas. Int J Transgenderism 2005 (online). https://doi.org/10.1300/J485v08n02_07Google Scholar
Bockting, W, Avery, E. Transgender health and HIV prevention: needs assessment studies from transgender communities across the United States – Introduction. Int J Transgenderism 2005 (online). https://doi.org/10.1300/J485v08n02_01Google Scholar
Thompson, LH, Dutta, S, Bhattacharjee, P, et al. Violence and mental health among gender-diverse individuals enrolled in a human immunodeficiency virus program in Karnataka, South India. Transgend Health 2019 (online). https://doi.org/10.1089/trgh.2018.0051CrossRefGoogle Scholar
Bukowski, LA, Hampton, MC, Escobar-Viera, CG, et al. Intimate partner violence and depression among Black transgender women in the USA: the potential suppressive effect of perceived social support. J Urban Health 2019 (online). https://doi.org/10.1007/s11524-019-00355-3Google Scholar
Sugano, E, Nemoto, T, Operario, D. The impact of exposure to transphobia on HIV risk behavior in a sample of transgendered women of color in San Francisco. AIDS Behav 2006 (online). https://doi.org/10.1007/s10461-005-9040-zGoogle Scholar
Operario, D, Nemoto, T. Sexual risk behavior and substance use among a sample of Asian Pacific Islander transgendered women. AIDS Educ Prev 2005 (online). https://doi.org/10.1521/aeap.2005.17.5.430Google Scholar
Wilson, EC, Garofalo, R, Harris, RD, et al. Transgender female youth and sex work: HIV risk and a comparison of life factors related to engagement in sex work. AIDS Behav 2009 (online). https://doi.org/10.1007/s10461-008-9508-8Google Scholar
Poteat, T, Scheim, A, Xavier, J, Reisner, S, Baral, S. Global epidemiology of HIV infection and related syndemics affecting transgender people. J Acquir Immune Defic Syndr 2016 (online). https://doi.org/10.1097/QAI.0000000000001087CrossRefGoogle Scholar
Reisner, SL, Jadwin-Cakmak, L, White Hughto, JM, et al. Characterizing the HIV prevention and care continua in a sample of transgender youth in the U.S. AIDS Behav 2017 (online). https://doi.org/10.1007/s10461-017-1938-8Google Scholar
Reback, CJ, Simon, P. The Los Angeles transgender health study: creating a research and community collaboration. Preventing AIDS: Community-Science Collaborations 2012 (online). https://doi.org/10.4324/9780203048306Google Scholar
Hoagland, B, Moreira, RI, De Boni, RB, et al. High pre-exposure prophylaxis uptake and early adherence among men who have sex with men and transgender women at risk for HIV Infection: the PrEP Brasil demonstration project. J Int AIDS Soc 2017 (online). https://doi.org/10.7448/IAS.20.1.21472Google Scholar
Chakrapani, V, Shunmugam, M, Rawat, S, et al. Acceptability of HIV pre-exposure prophylaxis among transgender women in India: a qualitative investigation. AIDS Patient Care STDS 2020 (online). https://doi.org/10.1089/apc.2019.0237Google Scholar
Socías, ME, Marshall, BDL, Arístegui, I, et al. Factors associated with healthcare avoidance among transgender women in Argentina. Int J Equity Health 2014 (online). https://doi.org/10.1186/s12939-014-0081-7Google Scholar
Sevelius, JM, Patouhas, E, Keatley, JG, Johnson, MO. Barriers and facilitators to engagement and retention in care among transgender women living with human immunodeficiency virus. Ann Behav Med 2014 (online). https://doi.org/10.1007/s12160-013-9565-8Google Scholar
Legal, L. When healthcare isn’t caring: Lambda Legal’s survey on discrimination against LGBT people and people living with HIV. Published 2010. Available at: www.lambdalegal.org/publications/when-health-care-isnt-caring.Google Scholar
Kammerer, N, Mason, T, Connors, M, et al. Transgenders, HIV/AIDS, and substance abuse: from risk group to group prevention. In Bockting, W, Kirk, S, Eds. Transgender & HIV: Risks, Prevention & Care. Binghampton, NY: The Haworth Press, 2001.Google Scholar
Kammerer, N, Mason, T, Connors, M, et al. Transgender health and social service needs in the context of HIV risk. In Bockting, W, Kirk, S, Eds. Transgender & HIV: Risks, Prevention & Care. Binghampton, NY: The Haworth Press, 2001.Google Scholar
Kenagy, GP. HIV among transgendered people. AIDS Care - Psychol Socio-Medical Asp AIDS/HIV 2002 (online). https://doi.org/10.1080/09540120220098008Google Scholar
Baguso, GN, Turner, CM, Santos, GM, et al. Successes and final challenges along the HIV care continuum with transwomen in San Francisco. J Int AIDS Soc 2019 (online). https://doi.org/10.1002/jia2.25270Google Scholar
Longman Marcellin, R, Bauer, GR, Scheim, AI. Intersecting impacts of transphobia and racism on HIV risk among trans persons of colour in Ontario, Canada. Ethn Inequalities Heal Soc Care 2013 (online). https://doi.org/10.1108/EIHSC-09-2013-0017Google Scholar
Ackerley, CG, Billingsley, JM, Tharp, GK, et al. Short communication:transgender women on feminizing hormone therapy demonstrate a distinct rectal mucosal transcriptome from cisgender men. AIDS Res Hum Retroviruses 2020 (online). https://doi.org/10.1089/aid.2020.0061Google Scholar
Shieh, E, Marzinke, MA, Fuchs, EJ, et al. Transgender women on oral HIV pre-exposure prophylaxis have significantly lower tenofovir and emtricitabine concentrations when also taking oestrogen when compared to cisgender men. J Int AIDS Soc 2019 (online). https://doi.org/10.1002/jia2.25405Google Scholar
Hiransuthikul, A, Janamnuaysook, R, Himmad, K, et al. Drug-drug interactions between feminizing hormone therapy and pre-exposure prophylaxis among transgender women: the iFACT study. J Int AIDS Soc 2019 (online). https://doi.org/10.1002/jia2.25338Google Scholar
Thomas, R, Pega, F, Khosla, R, et al. Ensuring an inclusive global health agenda for transgender people. Bull World Health Organ 2017 (online). https://doi.org/10.2471/BLT.16.183913Google Scholar
Center of Excellence for Transgender Health. Guidelines for the Primary and Gender-Affirming Care of Transgender and Gender Nonbinary People. Published 2016. University of California, San Francisco.Google Scholar
Peitzmeier, SM, Reisner, SL, Harigopal, P, Potter, J. Female-to-male patients have high prevalence of unsatisfactory Paps compared to non-transgender females: implications for cervical cancer screening. J Gen Intern Med 2014 (online). https://doi.org/10.1007/s11606-013-2753-1Google Scholar
Reisner, SL, Deutsch, MB, Peitzmeier, SM, et al. Test performance and acceptability of self- versus provider-collected swabs for high-risk HPV DNA testing in female-to-male trans masculine patients. PLoS One 2018 (online). https://doi.org/10.1371/journal.pone.0190172Google Scholar
U.S. Food and Drug Administration. FDA approves second drug to prevent HIV infection as part of ongoing efforts to end the HIV epidemic. Case Med Res 2019 (online). https://doi.org/10.31525/cmr-1e4dc7dGoogle Scholar
U.S. Food and Drug Administration. FDA approves first drug for reducing the risk of sexually acquired HIV infection. FDA Press Announcements.Google Scholar
UCSF Transgender Care Department of Family and Community Medicine, University of California San Francisco. Guidelines for the Primary and Gender-Affirming Care of Transgender and Gender Nonbinary People. University of California, San Francisco.Google Scholar
Gelman, M, van Wagenen, APJ. Principles for taking an LGBTQ-inclusive health history and conducting a culturally competent physical exam. In Makadon, H, Potter, J, Mayer, K, Goldhammer, H, Eds. Fenway Guide to Lesbian, Gay, Bisexual, and Transgender Health (2nd ed.). American College of Physicians, 2015, pp. 159–192.Google Scholar
Grant, JM, Mottet, LA, Tanis, J, et al. Injustice at Every Turn: A Report of the National Transgender Discrimination Survey. Washington National Center for Transgender Equality National Gay Lesbian Task Force. Published 2011. https://doi.org/10.1016/S0016-7878(90)80026-2Google Scholar
Substance Abuse and Mental Health Services Administration. SAMHSA’s concept of trauma and guidance for a trauma-informed approach. HHS Publication no. (SMA) 14-4884. Published 2014.Google Scholar
Meites, E, Szilagyi, PG, Chesson, HW, et al. Human papillomavirus vaccination for adults: updated recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep 2019 (online). https://doi.org/10.15585/mmwr.mm6832a3Google Scholar
Dubin, SN, Nolan, IT, Streed, CG Jr, et al. Transgender health care: improving medical students’ and residents’ training and awareness. Adv Med Educ Pract 2018 (online). https://doi.org/10.2147/amep.s147183Google Scholar
Deutsch, MB, Glidden, DV, Sevelius, J, et al. HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial. Lancet HIV 2015 (online). https://doi.org/10.1016/S2352-3018(15)00206-4Google Scholar

References

Dhillon, N, Oliffe, JL, Kelly, MT, Krist, J. Bridging barriers to cervical cancer screening in transgender men: a scoping review. Am J Mens Health 2020;14(3):1557988320925691. https://doi.org/10.1177/1557988320925691Google Scholar
McDowell, M, Pardee, DJ, Peitzmeier, S, et al. Cervical cancer screening preferences among trans-masculine individuals: patient-collected human papillomavirus vaginal swabs versus provider-administered pap tests. LGBT Health 2017;4(4):252–259.Google Scholar
Arbyn, M, Weiderpass, E, Bruni, L, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Global Health 2020;8(2): e191–e203.Google Scholar
de Martel, C, Plummer, M, Vignat, J, et al. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer 2017;141(4):664–670.Google Scholar
Safaeian, M, Solomon, D, Castle, PE. Cervical cancer prevention – cervical screening: science in evolution. Obstet Gynecol Clin North Am 2007;34(4):739–760. https://doi.org/10.1016/j.ogc.2007.09.004Google Scholar
Koh, W-J, Abu-Rustum, NR, Bean, S, et al. Cervical cancer, version 3.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 2019;17(1):64–84.Google Scholar
Curry, SJ, Krist, AH, Owens, DK, et al. Screening for cervical cancer: US Preventive Services Task Force recommendation statement. JAMA 2018;320(7): 674–686.Google Scholar
Reisner, SL, Deutsch, MB, Peitzmer, SM, et al. Comparing self- and provider-collected swabbing for HPV DNA testing in female-to-male transgender adult patients: a mixed-methods biobehavioral study protocol. BMC Infect Dis 2017;17:444.Google Scholar
Loughlin, KR. Cancer risk in the transgender community. Lancet Onc 2015;16(9):999.Google Scholar
Seay, J, Ranck, A, Weiss, R, et al. Understanding transgender men’s experiences with and preferences for cervical cancer screening: a rapid assessment survey. LGBT Health 2017;4(4):304–309.Google Scholar
American College of Obstetricians and Gynecologists. ACOG Committee Opinion No. 463: cervical cancer in adolescents: screening, evaluation, and management. Obstet Gynecol 2010;116(2 Pt 1):469–472.Google Scholar
Perkins, RB, Guido, RS, Castle, PE, et al. 2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis 2020;24(2):102.Google Scholar
Cooper, DB, Goyal, M. Colposcopy. StatPearls(online) 2020. See: www.ncbi.nlm.nih.gov/books/NBK564514/Google Scholar
Patel, JM, Dolitsky, S, Bachman, GA, et al. Gynecologic cancer screening in the transgender male population and its current challenges. Maturitas 2019;129:40–44.Google Scholar
Grynberg, M, Fanchin, R, Dubost, G, et al. Histology of genital tract and breast tissue after long-term testosterone administration in a female-to-male transsexual population. Reprod Biomed Online 2010;20(4):553–558.Google Scholar
Reisner, SL, Deutsch, MB, Peitzmeier, SM, et al. Test performance and acceptability of self- versus provider-collected swabs for high-risk HPV DNA testing in female-to-male trans masculine patients. PLoS One 2018;13(3):e0190172.Google Scholar
Wright, TC Jr, Denny, L, Kuhn, L, Pollack, A, Lorincz, A. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. JAMA 2000;283(1):81–86. https://doi.org/10.1001/jama.283.1.81Google Scholar
Greer, BE, Koh, WJ. New NCCN guidelines for vulvar cancer. J Natl Compr Canc Netw 2016; 14(5S):656–658.Google Scholar
Grosse, A, Grosse, C, Lenggenhager, D, et al. Cytology of the neovagina in transgender women and individuals with congenital or acquired absence of a natural vagina. Cytopathology 2017;28(3):184–191.Google Scholar
Van Damme, P, Olsson, SE, Block, S, et al. Immunogenicity and safety of a 9-valent HPV vaccine. Pediatrics 2015;136(1):e28–e39.Google Scholar
Pils, S, Joura, EA. From the monovalent to the nine-valent HPV vaccine. Clin Microbiol Infect 2015;21(9):827–833.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×